PDCD1 and cancer: Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD‐1), programmed death‐ligand 1 (PD‐L1), and cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) have been used to treat a variety of cancers.